Abstract
| Language | English |
|---|---|
| Article number | 17420 |
| Pages | 43596-43597 |
| Number of pages | 2 |
| Journal | Oncotarget |
| Volume | 8 |
| Issue number | 24 |
| DOIs | |
| Publication status | Published - 25 Apr 2017 |
Fingerprint
Keywords
- Sphingosine kinase 2
- multiple myeloma
- MM
- chemotherapeutic agents
- bortezomib
Cite this
}
Sphingosine kinase 2 and multiple myeloma. / Pyne, Nigel J.; Pyne, Susan.
In: Oncotarget, Vol. 8, No. 24, 17420, 25.04.2017, p. 43596-43597.Research output: Contribution to journal › Article
TY - JOUR
T1 - Sphingosine kinase 2 and multiple myeloma
AU - Pyne, Nigel J.
AU - Pyne, Susan
PY - 2017/4/25
Y1 - 2017/4/25
N2 - News on: Sphingosine kinase 2 inhibition synergises with bortezomib to target myeloma by enhancing endoplasmic reticulum stress, by Wallington-Beddoe et al. Oncotarget. 2017; doi: 10.18632/oncotarget.17115.
AB - News on: Sphingosine kinase 2 inhibition synergises with bortezomib to target myeloma by enhancing endoplasmic reticulum stress, by Wallington-Beddoe et al. Oncotarget. 2017; doi: 10.18632/oncotarget.17115.
KW - Sphingosine kinase 2
KW - multiple myeloma
KW - MM
KW - chemotherapeutic agents
KW - bortezomib
U2 - 10.18632/oncotarget.17420
DO - 10.18632/oncotarget.17420
M3 - Article
VL - 8
SP - 43596
EP - 43597
JO - Oncotarget
T2 - Oncotarget
JF - Oncotarget
SN - 1949-2553
IS - 24
M1 - 17420
ER -